Topic: How To Invest

Power Growth Investor Hotline – Friday, May 8, 2020

Article Excerpt

RESMED INC., $162.75, is a buy. The firm, symbol RMD on New York, helps investors tap the growing market for medical devices used to treat sleep apnea. ResMed’s CPAP (nasal continuous positive airway pressure) medical devices are used to treat patients with that chronic obstructive pulmonary disease as well as other respiratory conditions. In response to the COVID-19 pandemic, ResMed has ramped up production of life support ventilators, non-invasive ventilators, and ventilation mask systems. This should help keep its revenues and profits growing. Meanwhile, in the midst of COVID-19, there are many other patients who rely on ResMed ventilators every day to assist their breathing. A large number of these patients require regular check-ups and support from hospitals, physicians, and homecare providers; to protect patients and medical staff alike, innovations such as telehealth and telemonitoring have become critical services. To meet that need, ResMed continues to upgrade its AirView cloud-based remote monitoring software for its ventilators. With AirView, clinicians and care providers can…